What are the main side effects of NAD+ Precursors (NMN/NR)?

NAD+ Precursors (NMN/NR) side effects and warning signals include Mild nausea, Flushing, Headache, Gastrointestinal discomfort, and Insomnia at high doses.

What evidence level is NAD+ Precursors (NMN/NR)?

NAD+ Precursors (NMN/NR) is rated Level B; the listed research status is Phase 2.

Anti-Aging & Longevity / Level B / Phase 2 / Last reviewed 2026-04-04

NAD+ Precursors (NMN/NR) Evidence Guide

NAD+ precursors (NMN/NR) have Phase 2 human data demonstrating reliable NAD+ elevation in blood, with emerging evidence for metabolic, cardiovascular, and muscle function benefits. The evidence is not yet at Phase 3 scale for any single indication, but the mechanistic foundation and human safety data are solid across multiple independent groups. For longevity-adjacent interventions with actual human data, NAD+ precursors are the most evidence-supported option in this category.

Our Take

Best for: NAD+ restoration, metabolic aging research, cardiovascular risk factor modulation, muscle function in aging
Evidence grade: Level B
Confidence: Moderate
Starting point: 500mg NMN or NR oral daily (morning dosing)

Benefits and Evidence

Cellular NAD+ Restoration: Level B, includes human evidence - Multiple human trials confirm oral NMN and NR supplementation significantly raises blood NAD+ levels within weeks of daily dosing.
Mitochondrial Function: Level B, includes human evidence - Improved mitochondrial respiration and ATP production observed in skeletal muscle of older adults supplemented with NR or NMN.
Insulin Sensitivity: Level C, includes human evidence - Some RCTs show modest improvements in insulin sensitivity with NMN supplementation in prediabetic women, though results are not yet consistent across populations.

Side Effects and Warnings

Mild nausea
Flushing
Headache
Gastrointestinal discomfort
Insomnia at high doses
Long-term safety data beyond 12 months is limited
Theoretical concern about promoting growth of existing cancers via NAD+-dependent pathways
Quality and purity of supplements vary significantly between manufacturers

Research Dosage References

<strong>Oral</strong> - 250-1000 mg/day (NMN) - Once daily - Most human trials use 250-500 mg/day. Higher doses appear safe but do not proportionally increase NAD+ levels.
<strong>Oral</strong> - 300-1000 mg/day (NR) - Once or twice daily - NR (as Niagen) has been used in multiple clinical trials at 300-1000 mg/day with good tolerability.

Mechanism of Action

NMN and NR are converted to NAD+ through the salvage pathway. NMN is phosphorylated by nicotinamide phosphoribosyltransferase (NAMPT) and then converted to NAD+ by NMN adenylyltransferases (NMNATs). Elevated NAD+ levels activate sirtuins (SIRT1-7), PARP DNA repair enzymes, and CD38/CD157 signaling molecules, collectively supporting genomic stability, mitochondrial biogenesis, and cellular stress resistance.

Legal Status

Available as dietary supplement in most countries; NMN banned as supplement in some jurisdictions pending further review.

Primary Sources

Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners. Journal of the International Society of Sports Nutrition, 2021.
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 2018.
NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 2021.